Charles River Labs Intl buy UBS Group AG
Start price
15.02.24
/
50%
€227.80
Target price
15.02.25
€269.47
Performance (%)
-18.15%
Price
03.07.24
€186.45
Summary
This prediction is currently active. The price of Charles River Labs Intl has decreased since the start of the prediction. Compared to the start price this results in a performance of -18.15%. This prediction currently runs until 15.02.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -3.319% | -3.319% |
iShares Core DAX® | 1.395% | -0.696% |
iShares Nasdaq 100 | 2.287% | 7.501% |
iShares Nikkei 225® | 1.617% | 2.769% |
iShares S&P 500 | 0.659% | 4.280% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at UBS Group AG from $270.00 to $290.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
17.30%
03.07.24
03.07.24